The price of arabica coffee beans climbed to a 32-month high in early October, continuing a months-long upward trend that has driven up costs for coffee retailers and consumers just […]
Forklift and truck-lift equipment manufacturer The Raymond Corporation, a division of Toyota Material Handling USA, announced the appointment of Michael Field to the position of CEO. Field has been with the company since 2004 and has been at the head of the company’s Operations and Engineering division since 2009. Prior to Raymond, he held executive positions in product development, program management, and systems engineering for Brooks-PRI Automation and Carrier Corporation.
March 16, 2015
In an update last week, Dun & Bradstreet editor Adam Anderson detailed how Southwest Airlines‘ simple approach (low cost, no frills) — combined with a steep decline in fuel and oil prices — led to milestone revenue and net income in 2014. It reported revenue of $18.6 billion last year, with net income of $1.1 billion. A key to future growth for the airline is international service; in 2014 the company launched service to Jamaica, Aruba, and the Bahamas, with plans this year for service to Costa Rica and Belize, among other destinations. Follow Adam on Twitter.
March 23, 2015
FDA approval of the first copycat version of a biotech drug opens the gates on a new market that could help some drug manufacturers but hurt others. Pharmaceutical companies have invested heavily in development of patent-protected biologic drugs, which are produced through manipulation of living cells (as opposed to chemical substances). Though several copycat biotech drugs, known as biosimilars, are sold in Europe and other regions, Novartis’ Zarxio for treatment of chemotherapy-related infections (a generic version of Amgen’s Neupogen) is the first biosimilar approved for sale in the US, after much debate. For more industry trends, please see our Pharmaceutical Manufacturing profile.